Mutational analysis of Mdm2 C-terminal tail suggests an evolutionarily conserved role of its length in Mdm2 activity toward p53 and indicates structural differences between Mdm2 homodimers and Mdm2/MdmX heterodimers

被引:30
|
作者
Dolezelova, Pavlina [1 ]
Cetkovska, Katerina [1 ]
Vousden, Karen H. [2 ]
Uldrijan, Stjepan [1 ]
机构
[1] Masaryk Univ, Dept Biol, Fac Med, Brno, Czech Republic
[2] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland
关键词
p53; Mdm2; RING domain; ubiquitylation; ubiquitin ligase; E3; UBIQUITIN-PROTEIN LIGASE; RING DOMAIN; MUTANTS; GENES; TWIST;
D O I
10.4161/cc.11.5.19445
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mdm2 can mediate p53 ubiquitylation and degradation either in the form of the Mdm2 homodimer or Mdm2/MdmX heterodimer. The ubiquitin ligase activity of these complexes resides mainly in their respective RING finger domains and also requires adjacent C-terminal tails. So far, structural studies have failed to show significant differences between Mdm2 RING homodimers and Mdm2/MdmX RING heterodimers. Here, we report that not only the primary amino acid sequence, but also the length of the C-terminal tail of Mdm2 is highly conserved through evolution and plays an important role in Mdm2 activity toward p53. Mdm2 mutants with extended C termini do not ubiquitylate p53 despite being capable of forming Mdm2 homodimers through both RING-acidic domain and RING-RING interactions. All extended mutants also retained the ability to interact with MdmX, and this interaction led to reactivation of their E3 ubiquitin ligase activity. In contrast, only a subset of extended Mdm2 mutants was activated by the interaction with Mdm2 RING domain, suggesting that Mdm2 homodimers and Mdm2/MdmX heterodimers may not be structurally and functionally fully equivalent.
引用
收藏
页码:953 / 962
页数:10
相关论文
共 50 条
  • [1] Binding of an inhibitor of the p53/MDM2 interaction to MDM2
    Duncan, SJ
    Cooper, MA
    Williams, DH
    [J]. CHEMICAL COMMUNICATIONS, 2003, (03) : 316 - 317
  • [2] The contribution of the acidic domain of MDM2 to p53 and MDM2 stability
    Manuela Argentini
    Nadia Barboule
    Bohdan Wasylyk
    [J]. Oncogene, 2001, 20 : 1267 - 1275
  • [3] The contribution of the acidic domain of MDM2 to p53 and MDM2 stability
    Argentini, M
    Barboule, N
    Wasylyk, B
    [J]. ONCOGENE, 2001, 20 (11) : 1267 - 1275
  • [4] A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control
    Li, LM
    Liao, J
    Ruland, J
    Mak, TW
    Cohen, SN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (04) : 1619 - 1624
  • [5] Mdm2 and MdmX: Partners in p53 Destruction
    Manfredi, James J.
    [J]. CANCER RESEARCH, 2021, 81 (07) : 1633 - 1634
  • [6] Regulation of p53: a collaboration between Mdm2 and MdmX
    Pei, Dongsheng
    Zhang, Yanping
    Zheng, Junnian
    [J]. ONCOTARGET, 2012, 3 (03) : 228 - 235
  • [7] Mdm2 and MdmX partner to regulate p53
    Wang, Xinjiang
    Jiang, Xuejun
    [J]. FEBS LETTERS, 2012, 586 (10) : 1390 - 1396
  • [8] P53 Mdm2 Inhibitors
    Khoury, Kareem
    Doemling, Alex
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (30) : 4668 - 4678
  • [9] MDM2与p53
    金晶
    刘耕陶
    [J]. 癌症, 2001, (06) : 663 - 666
  • [10] p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
    Christine Wasylyk
    Roberto Salvi
    Manuela Argentini
    Christine Dureuil
    Isabelle Delumeau
    Joseph Abecassis
    Laurent Debussche
    Bohdan Wasylyk
    [J]. Oncogene, 1999, 18 : 1921 - 1934